Classification | Adverse event | Number | Risk of AE per 1000 neonates | 95% CI |
---|---|---|---|---|
Gastrointestinal | Vomiting | 12 | 37 | 21 to 64 |
Feeding intolerance/poor feeding | 10 | 31 | 16 to 57 | |
NEC | 8 | 25 | 12 to 49 | |
Abdominal tenderness | 6 | 19 | 8 to 41 | |
Diarrhoea | 4 | 12 | 5 to 33 | |
Other gastrointestinal symptoms | 13 | 40 | 24 to 68 | |
Total gastrointestinal AE | 53 | 163 | 128 to 209 | |
Respiratory | BPD | 96 | 296 | 251 to 350 |
Respiratory distress | 1 | 3 | 4 to 22 | |
Total respiratory AE | 97 | 299 | 253 to 354 | |
CNS | At least grade 3 IVH | 29 | 90 | 63 to 127 |
Abnormal hearing | 22 | 68 | 45 to 102 | |
PVL | 15 | 46 | 28 to 76 | |
Others | 4 | 12 | 5 to 33 | |
74 | 228 | 187 to 279 | ||
Hepatobiliary | Elevated transaminase | 16 | 49 | 31 to 80 |
Cardiovascular | PDA | 20 | 62 | 40 to 94 |
Metabolic | Hyperkalaemia | 2 | 6 | 2 to 25 |
Others | Sepsis | 11 | 34 | 19 to 61 |
Other infections | 96 | 296 | 251 to 350 | |
Allergy | 2 | 6 | 2 to 25 | |
Total | 371 |
AEs, adverse event; BPD, bronchopulmonary dysplasia; RCT, randomised controlled trials.